Table 2. Number and percent of significant genes (mixed model ANOVA, p < 0.01 and pFDR < 0.05) of 6,789 analyzed due to population, treatment, and stage alone, and population-by-treatment, population-by-stage, treatment-by-stage, and population-by-treatment-by-stage interactions.
Population | Treatment | Stage | Population X Treatment | Population X Stage | Treatment X Stage | Population X Treatment X Stage | |
---|---|---|---|---|---|---|---|
# Sig. Genes (p < 0.01) | 85 | 270 | 367 | 431 | 108 | 118 | 114 |
% Sig. Genes (p < 0.01) | 1.25 | 3.98 | 5.41 | 6.35 | 1.59 | 1.74 | 1.68 |
# Sig. Genes pFDR (p < 0.05) | 34 | 63 | 196 | 53 | 39 | 59 | 36 |
17.35% (1,178 genes) were significantly differently expressed (mixed model ANOVA, p < 0.01).